The First Family Group of Α1-at-p in the World with Repeated Hematomas: 10-Year Follow-Up

S. Luo,X. Ruan,Y. Wang,X. Li,Z. Xu,M. Min,M. Li,L. Zhang,Y. Li,H. Wang,J. Cheng,A. O. Mueck

DOI: https://doi.org/10.1080/13697137.2019.1611762

2019-01-01

Climacteric

Abstract:This case report describes the first 10-year follow-up report worldwide of a patient with the genetic variation alpha-1-antitrypsin-Pittsburgh mutation (alpha 1-AT-P). The mutation was confirmed in a 16 year-old Chinese girl after she presented with repeated hematomas, and the mutation with bleeding tendency was also verified in her father. alpha 1-AT-P is a spontaneously occurring autosomal dominant point mutation of alpha 1-antitrypsin, in which methionine-358 is substituted by an arginine derivative. alpha 1-AT-P cases are extremely rare, with only eight reported worldwide. Consequently, there is insufficient experience in the diagnosis and treatment of alpha 1-AT-P. We followed up and reviewed the last 10 years of treatment of a young patient who suffered from repeated life-threatening hematomas, underwent emergency surgery five times, and had her ovaries removed in her twenties to avoid ovulation hemorrhage. The purpose of this article is to raise the awareness of alpha 1-AT-P mutation and to improve its prognosis, especially in female patients.